Neck Cancer

News Neck Cancer

• Sentinel node biopsy safe, effective in head and neck melanomas, U-M study finds

  A common technique for determining whether melanoma has spread can be used safely and effectively even in tumors from the head and neck area, according to a new study from the University of Michigan Comprehensive Cancer Center. Sentinel lymph node biopsy involves injecting a special dye to identify more

• CT Atlantic AG Announces Appointment of Thomas Lander to the Board of Directors

  CT Atlantic AG announced the appointment of Dr. Thomas Lander to its board of directors. Thomas Lander provides CT Atlantic with long-standing, global pharmaceutical experience in early through late stage drug development and in regulatory affairs. Dr. Lander was previously Managing Director of Cur more

• Idera Pharmaceuticals Achieves Clinical Milestone Under Its Collaboration with Merck KGaA for Cancer Treatment

  Idera Pharmaceuticals, Inc. announced that it has achieved a milestone under its worldwide licensing and collaboration agreement with Merck KGaA. The milestone was achieved upon Merck KGaA’s initiation of a Phase 1b clinical trial of IMO-2055 (EMD 1201081), an agonist of Toll-like Receptor 9 (TLR9), more

Publications Neck Cancer

• Integrated Therapeutic Approaches in Head and Neck Cancer: The Importance of Multidisciplinary Team Management

  Abstract: Multidisciplinary team (MDT) is of paramount importance in the approach to patients with head and neck cancer. Its aim is to provide the best diagnostic work-up, tumor staging, and treatment. Furthermore, the prognosis of patients who are managed by MDT is usually better. MDT has more

• Hedgehog Signaling Alters Reliance on EGF Receptor Signaling and Mediates Anti-EGFR Therapeutic Resistance in Head and Neck Cancer

  The EGF receptor (EGFR)-directed monoclonal antibody cetuximab is the only targeted therapy approved for the treatment of squamous cell carcinoma of the head and neck (HNSCC) but is only effective in a minority of patients. Epithelial-to-mesenchymal transition (EMT) has been implicated as a drug res more

• miR145 Targets the SOX9/ADAM17 Axis to Inhibit Tumor-Initiating Cells and IL-6–Mediated Paracrine Effects in Head and Neck Cancer

  ALDH1+CD44+ cells are putative tumor-initiating cells (TIC) in head and neck squamous cell carcinomas (HNC). miR-145 regulates tumorigenicity in various cancers but the breadth of its mechanistic contributions and potential therapeutic applications are not completely known. Here, we report that ALDH more

Market studies Neck Cancer

• Head And Neck Cancer – Pipeline Review, H1 2012

  Introduction Global Markets Direct’s, 'Head and Neck Cancer - Pipeline Review, H1 2012', provides an overview of the Head and Neck Cancer therapeutic pipeline. This report provides information on the therapeutic development for Head and Neck Cancer, complete with latest updates, and special featur more

• Novel Therapies in Oncology - Protein Kinase Inhibitors, Monoclonal Antibodies and Vaccines Therapeutic Classes Dominate Late-Stage Pipeline

  GBI Research, the leading business intelligence provider, has released its latest research, “Novel Therapies in Oncology - Protein Kinase Inhibitors, Monoclonal Antibodies and Vaccines Therapeutic Classes Dominate Late-Stage Pipeline” which provides insights into the global oncology pipeline. The re more

• Head And Neck Cancer Squamous Cell Carcinoma – Pipeline Review, H2 2012

  Introduction Global Markets Direct’s, 'Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Head And Neck Cancer Squamous Cell Carcinoma, complete more

Websites Neck Cancer